JP2004528803A5 - - Google Patents

Download PDF

Info

Publication number
JP2004528803A5
JP2004528803A5 JP2001584514A JP2001584514A JP2004528803A5 JP 2004528803 A5 JP2004528803 A5 JP 2004528803A5 JP 2001584514 A JP2001584514 A JP 2001584514A JP 2001584514 A JP2001584514 A JP 2001584514A JP 2004528803 A5 JP2004528803 A5 JP 2004528803A5
Authority
JP
Japan
Prior art keywords
antibody
seq
amino acid
nucleic acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001584514A
Other languages
English (en)
Japanese (ja)
Other versions
JP4819285B2 (ja
JP2004528803A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/014468 external-priority patent/WO2001088132A2/en
Publication of JP2004528803A publication Critical patent/JP2004528803A/ja
Publication of JP2004528803A5 publication Critical patent/JP2004528803A5/ja
Application granted granted Critical
Publication of JP4819285B2 publication Critical patent/JP4819285B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001584514A 2000-05-16 2001-05-04 狂犬病ウイルス特異的ヒトモノクローナル中和抗体及び核酸及び関連する方法 Expired - Fee Related JP4819285B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20451800P 2000-05-16 2000-05-16
US60/204,518 2000-05-16
PCT/US2001/014468 WO2001088132A2 (en) 2000-05-16 2001-05-04 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods

Publications (3)

Publication Number Publication Date
JP2004528803A JP2004528803A (ja) 2004-09-24
JP2004528803A5 true JP2004528803A5 (cg-RX-API-DMAC7.html) 2008-06-19
JP4819285B2 JP4819285B2 (ja) 2011-11-24

Family

ID=22758233

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001584514A Expired - Fee Related JP4819285B2 (ja) 2000-05-16 2001-05-04 狂犬病ウイルス特異的ヒトモノクローナル中和抗体及び核酸及び関連する方法

Country Status (9)

Country Link
US (1) US6890532B2 (cg-RX-API-DMAC7.html)
EP (1) EP1282703B1 (cg-RX-API-DMAC7.html)
JP (1) JP4819285B2 (cg-RX-API-DMAC7.html)
AT (1) ATE411387T1 (cg-RX-API-DMAC7.html)
CA (1) CA2419148C (cg-RX-API-DMAC7.html)
DE (1) DE60136174D1 (cg-RX-API-DMAC7.html)
IL (1) IL152825A (cg-RX-API-DMAC7.html)
RU (1) RU2272809C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001088132A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013672A1 (en) * 2000-05-16 2004-01-22 Thomas Jefferson University Recombinant antibodies, and compositions and methods for making and using the same
US20020115143A1 (en) * 2000-08-24 2002-08-22 Bernhard Dietzschold Rhabdovirus-based vectors to express high levels of functional human antibodies
ATE557040T1 (de) * 2001-08-21 2012-05-15 Univ Jefferson Rekombinante antikörper sowie zusammensetzungen und verfahren zu deren herstellung und verwendung
US7084257B2 (en) 2001-10-05 2006-08-01 Amgen Inc. Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
NZ537277A (en) 2002-07-18 2008-04-30 Crucell Holland Bv Recombinant production of mixtures of antibodies
WO2004106375A1 (en) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
EP1737971B1 (en) 2004-01-20 2017-08-16 Merus N.V. Mixtures of binding proteins
DK1851315T3 (en) 2005-02-02 2014-03-24 Univ Massachusetts HUMAN ANTIBODIES AGAINST RABIES AND APPLICATIONS THEREOF
JP2008263964A (ja) * 2007-03-29 2008-11-06 Yamaguchi Univ コウモリ由来細胞株
JP2010085126A (ja) * 2008-09-29 2010-04-15 Adtec Kk 狂犬病ウイルス中和抗体価判定具および狂犬病ウイルス中和抗体価の測定方法
WO2012128508A2 (ko) * 2011-03-18 2012-09-27 (주)셀트리온 광견병 바이러스를 중화시킬 수 있는 결합 분자
WO2013157953A1 (en) 2012-04-20 2013-10-24 Merus B.V. Methods and means for the production of ig-like molecules
RU2533802C1 (ru) * 2013-08-30 2014-11-20 федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Тримеризованное однодоменное антитело, специфически связывающееся с гликопротеином g вируса бешенства, нейтрализующее вирус бешенства
WO2019227039A1 (en) * 2018-05-24 2019-11-28 Lankenau Institute For Medical Research Compositions comprising antibodies to rabies virus and the uses thereof
CN111166877A (zh) * 2019-12-30 2020-05-19 西安回天血液制品有限责任公司 一种狂犬病人免疫球蛋白的制备方法
CN114958774B (zh) * 2022-05-08 2023-10-27 中国医学科学院医学生物学研究所 抗狂犬病病毒单克隆抗体及分泌该抗体的杂交瘤细胞株与应用
CN119431525B (zh) * 2024-10-08 2025-04-11 北京溯本源和生物科技有限公司 狂犬病毒g蛋白重组抗原、单克隆抗体及其制备方法和应用
CN122011169B (zh) * 2026-04-15 2026-07-21 北京纳百生物科技有限公司 一种抗狂犬病毒g蛋白的单克隆抗体、检测试剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
IL89489A0 (en) 1988-03-09 1989-09-10 Hybritech Inc Chimeric antibodies directed against human carcinoembryonic antigen
EP0404836A1 (en) * 1988-04-07 1991-01-02 FARMITALIA CARLO ERBA S.r.l. Human monoclonal antibodies against rabies virus
KR900700134A (ko) 1988-04-15 1990-08-11 원본미기재 Il-2 수용체-특이적 키메릭 항체
ATE119198T1 (de) 1988-04-16 1995-03-15 Celltech Ltd Verfahren zur herstellung von proteinen mittels rekombinanter dna.
AU4025193A (en) 1992-04-08 1993-11-18 Cetus Oncology Corporation Humanized C-erbB-2 specific antibodies

Similar Documents

Publication Publication Date Title
JP2019195335A5 (cg-RX-API-DMAC7.html)
JP2002503495A5 (cg-RX-API-DMAC7.html)
CY1109715T1 (el) IL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ
JP2022534135A5 (cg-RX-API-DMAC7.html)
RU2007140978A (ru) Пассивная иммунизационная терапия на основе пептидов для лечения атеросклероза
CA2466629A1 (en) Expression control using variable intergenic sequences
JP2006526414A5 (cg-RX-API-DMAC7.html)
WO2001070174A3 (en) Vegf-modulated genes and methods employing them
CA2419148A1 (en) Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
FI3715372T3 (fi) Suuren affiniteetin humaaneja vasta-aineita ihmisen IL-4-reseptorille
CA2288962A1 (en) Human monoclonal antibodies to epidermal growth factor receptor
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
ATE420964T1 (de) Polycistronische expression von antikörpern in cho zellen
DK1392359T4 (da) Specifikke bindingsproteiner og deres anvendelser.
WO2003031475A3 (en) Antibodies against kdr, their production and uses
RU2002133470A (ru) Специфичные в отношении вируса бешенства нейтрализующие моноклональные антитела человека и нуклеиновые кислоты, и связанные с ними способы
WO2001046224A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
CA2474801A1 (en) Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
CA2457362A1 (en) Human monoclonal rabies virus neutralizing antibodies, and methods for making and using the same
JP2025090679A5 (cg-RX-API-DMAC7.html)
EP2172214A3 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
FI4172199T3 (fi) Alfa-synukleiinin protofibrilliin sitoutuvat vasta-aineet
WO1996021020A3 (en) Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
CN112851771A (zh) 连接核酸与蛋白或肽的方法
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof